grant

VIRAL GENE THERAPY FOR MENKES DISEASE

Organization BATTELLE CENTERS/PUB HLTH RES & EVALUATNLocation COLUMBUS, UNITED STATESPosted 30 Sept 2024Deadline 29 Sept 2027
NIHUS FederalResearch GrantFY2024Congenital HypocupremiaCooperative AgreementsDNA TherapyDiseaseDisorderFundingGene Transfer ClinicalGenetic InterventionKinky Hair DiseaseKinky Hair SyndromeMenkes Kinky Hair SyndromeMenkes SyndromeMenkes diseaseNINDSNational Institute of Neurological Diseases and StrokeNational Institute of Neurological Disorders and StrokeSteely Hair DiseaseSteely Hair SyndromeToxicologyU-Series Cooperative AgreementsViral GenesX-linked copper malabsorptionanimal safetycongenital hypocupraemia syndromegene repair therapygene therapygene-based therapygenetic therapygenomic therapypre-clinicalpreclinicaltrichopoliodystrophy
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Currently, the National Institute of Neurological Disorders and Stroke (NINDS), via its URGenT network,
is funding a cooperative agreement for the pre-clinical animal safety, efficacy, and toxicology studies for

the treatment of Menkes disease.

Grant Number: 75N95022D00021-0-759502400003-1
NIH Institute/Center: NIH

Principal Investigator: Amanda Burnaugh

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
VIRAL GENE THERAPY FOR MENKES DISEASE — BATTELLE CENTERS/PUB HLTH RES & EVALUATN | UNITED STATES | Sept 2024 | Dev Procure